Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Condition:   AsthmaInterventions:   Drug: Albuterol Spiromax®;   Drug: ProAir® HFASponsors:   Teva Pharmaceutical Industries;   Teva Pharmaceutical IndustriesActive, not recruiting - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2013 Category: Research Source Type: clinical trials

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Condition:   AsthmaInterventions:   Drug: Albuterol Spiromax®;   Drug: ProAir® HFASponsors:   Teva Pharmaceutical Industries;   Teva Pharmaceutical IndustriesActive, not recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2013 Category: Research Source Type: clinical trials

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Condition:   AsthmaInterventions:   Drug: Albuterol Spiromax®;   Drug: ProAir® HFASponsors:   Teva Pharmaceutical Industries;   Teva Pharmaceutical IndustriesActive, not recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2013 Category: Research Source Type: clinical trials

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Condition:   AsthmaInterventions:   Drug: Albuterol Spiromax®;   Drug: ProAir® HFASponsor:   Teva Pharmaceutical IndustriesActive, not recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2013 Category: Research Source Type: clinical trials

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Condition:   AsthmaInterventions:   Drug: Albuterol Spiromax®;   Drug: ProAir® HFASponsor:   Teva Pharmaceutical IndustriesCompleted - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2013 Category: Research Source Type: clinical trials

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition:   LymphangioleiomyomatosisInterventions:   Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizerSponsor:   National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2013 Category: Research Source Type: clinical trials

Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
Condition:   Exercise-Induced Bronchoconstriction (EIB)Interventions:   Drug: Albuterol Spiromax;   Drug: Placebo SpiromaxSponsor:   Teva Pharmaceutical IndustriesCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2013 Category: Research Source Type: clinical trials

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition:   AsthmaInterventions:   Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisoloneSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2011 Category: Research Source Type: clinical trials

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition:   AsthmaInterventions:   Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisoloneSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2011 Category: Research Source Type: clinical trials

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition:   AsthmaInterventions:   Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisoloneSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2011 Category: Research Source Type: clinical trials

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition:   AsthmaInterventions:   Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisoloneSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2011 Category: Research Source Type: clinical trials

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition:   AsthmaInterventions:   Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisoloneSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2011 Category: Research Source Type: clinical trials